¿Û¿Û´«Ã½

Serco unveils buyback amid well-timed shift to defence

Outsourcer beat its free cash flow guidance as new contract wins overpower lower immigration revenue

Spire struggles with lower health budgets

Tighter NHS commissioning has left a sale as Spire’s main strategic option

Endeavour Mining’s free cash flow surges again

The gold miner still sees a West Africa discount despite moving out of higher-risk areas

This big and dirty chemicals stock is cleaning up its act

The behemoth was once a poster child for industrial decline but there are strong signs of recovery

Things are looking sticky for this ‘jam tomorrow’ stock

Weakened growth prospects and customer departures mean it’s time to cut your losses

How to invest in the healthcare revival

Pharma and medtech stocks can offer investors safety if and when Big Tech falters. We highlight where to look

Grafton remains resilient in tough markets

The builders’ merchant battles through difficult sector conditions, but geographic diversity helps

Ibstock earnings dip as market shows few signs of recovery

The brickmaker is still waiting for demand to improve

Foxtons hopes to benefit from Labour’s new rental rules

The estate agency spies cross-selling and M&A opportunities

This high-yield and low-rated manufacturer is performing well

Simon Thompson: A low PE ratio, solid dividend and staggering share price discount highlight its re-rating potential